scispace - formally typeset
Open AccessJournal ArticleDOI

microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2

Reads0
Chats0
TLDR
Functional and mechanistic links between miRNA-224 and the tumor suppressors PHLPP1 and PHL PP2 in the pathogenesis of colorectal cancer are revealed.
Abstract
Purpose: To investigate the clinicopathologic significance, role, and mechanism of action of microRNA-224 (miR-224) in colorectal cancer. Experimental Design: Real-time PCR was used to quantify miR-224 expression. The association of miR-224 with the clinicopathologic features and survival was evaluated in 110 colorectal cancer patients. The role of miR-224 in colorectal cancer was investigated using in vitro and in vivo assays. Luciferase reporter assays were conducted to confirm target gene associations. Results: miR-224 was overexpressed in colorectal cancer. High-level expression of miR-224 was significantly associated with an aggressive phenotype and poor prognosis. Overexpression of miR-224 promoted colorectal cancer cell proliferation in vitro and tumor growth in vivo . Specifically, miR-224 accelerated the G 1 –S phase transition through activation of AKT/FOXO3a signaling, downregulation of p21Cip1 and p27Kip1, and upregulation of cyclin D1. Moreover, both PH domain leucine-rich-repeats protein phosphatase 1 ( PHLPP1 ) and PHLPP2 , antagonists of PI3K/AKT signaling, were confirmed as bona fide targets of miR-224. miR-224 directly targeted the 3′-untranslated regions of the PHLPP1 and PHLPP2 mRNAs and repressed their expression. Conclusion: This study reveals functional and mechanistic links between miRNA-224 and the tumor suppressors PHLPP1 and PHLPP2 in the pathogenesis of colorectal cancer. miR-224 not only plays important roles in the regulation of cell proliferation and tumor growth in colorectal cancer, but also has potential as a prognostic marker or therapeutic target for colorectal cancer. Clin Cancer Res; 19(17); 4662–72. ©2013 AACR .

read more

Citations
More filters
Journal ArticleDOI

Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin.

TL;DR: The rapidly advancing field of ATx in cancer therapy as well as some molecular targets of ATX are reviewed, showing great promise as chemotherapeutic agents in cancer.
Journal ArticleDOI

MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer

TL;DR: Up-regulated miR-224 facilitates tumor progression by shifting the equilibrium of the partially antagonist functions of SMAD4 and TNFAIP1 toward enhanced invasion and growth in NSCLC, and indicates that targeting miD-224 could be effective in the treatment of certain lung cancer patients.
Journal ArticleDOI

Small molecule compounds targeting miRNAs for cancer therapy

TL;DR: A novel therapeutic strategy that is only at the tip of the iceberg is presented: the use of small molecule inhibitors to target specific miRNAs (SMIRs) both in vitro and in silico.
Journal ArticleDOI

MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity

TL;DR: Recent evidence demonstrating the potential role of miRNA in CRC and the implications of its use in the diagnosis, prognosis, and management of CRC are reviewed.
References
More filters
Journal ArticleDOI

The functions of animal microRNAs

TL;DR: Evidence is mounting that animal miRNAs are more numerous, and their regulatory impact more pervasive, than was previously suspected.
Journal ArticleDOI

Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor

TL;DR: It is demonstrated that Akt also regulates the activity of FKHRL1, a member of the Forkhead family of transcription factors, which triggers apoptosis most likely by inducing the expression of genes that are critical for cell death, such as the Fas ligand gene.
Journal ArticleDOI

MicroRNA signatures in human cancers

TL;DR: MiRNA-expression profiling of human tumours has identified signatures associated with diagnosis, staging, progression, prognosis and response to treatment and has been exploited to identify miRNA genes that might represent downstream targets of activated oncogenic pathways, or that target protein-coding genes involved in cancer.
Journal Article

MicroRNA signatures in human cancers

TL;DR: The causes of the widespread differential expression of miRNA genes in malignant compared with normal cells can be explained by the location of these genes in cancer-associated genomic regions, by epigenetic mechanisms and by alterations in the miRNA processing machinery as discussed by the authors.
Journal ArticleDOI

MicroRNAs: small RNAs with a big role in gene regulation

TL;DR: Two founding members of the microRNA family were originally identified in Caenorhabditis elegans as genes that were required for the timed regulation of developmental events and indicate the existence of multiple RISCs that carry out related but specific biological functions.
Related Papers (5)